Ziopharm Oncology reported $1.51M in Trade Debtors for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Amgen AMGN:US $ 4765M 286M
AstraZeneca AZN:LN 8.85B 2.01B
Baxter International BAX:US $ 2074M 53M
Biogen BIIB:US $ 2123M 12.8M
Bioline Rx BLRX:US $ 0.19M 0.48M
Bristol Myers Squibb BMY:US $ 9245M 2030M
Corcept Therapeutics CORT:US $ 26.51M 1.11M
Curis CRIS:US $ 2.96M 0.58M
Eleven Biotherapeutics EBIO:US 1.11M 1.2M
Gilead Sciences GILD:US $ 4566M 417M
GlaxoSmithKline GSK:LN 8.28B 777M
Intrexon XON:US $ 21.08M 5.59M
Karyopharm Therapeutics KPTI:US $ 18.75M 865K
Novartis NOVN:VX 8.63B 22M
Ptc Therapeutics PTCT:US $ 96.64M 17.84M
Regeneron Pharmaceuticals REGN:US $ 5452M 1546.6M
Sangamo Biosciences SGMO:US $ 8.59M 0.9M
Verastem VSTM:US $ 0.1M 0.37M
YTE INCY:US $ 516.69M 78.52M
Ziopharm Oncology ZIOP:US $ 1.51M 6.12M